• Cancer Screening

    Fox Chase Took Charge at Miles for Melanoma 2015

    by  • August 20, 2015 • Cancer Screening, Melanoma, Skin Cancer, Special events

    Joining the likes of elephants, bears, alligators and tigers, Fox Chase Cancer Center faculty, staff and patients took charge at the Philadelphia Zoo on Sunday, August 16, 2015, at the first annual Miles for Melanoma 5K. The event was sponsored by the Melanoma Research Foundation. As captain of our team, I couldn’t have been...

    Read more →

    Reaching Young Adults: Development of an Internet Intervention for Skin Cancer Prevention

    by  • June 23, 2015 • Cancer Research, Cancer Screening, Skin Cancer

    By Carolyn Heckman, PhD, Associate Professor, Fox Chase Cancer Center Several studies have shown that young adults 18 to 25 years old commonly expose themselves to ultraviolet (UV) radiation, either from the sun or indoor tanning, without using sunscreen or other skin protection. This exposure is a known risk factor for skin cancer, which...

    Read more →

    Fox Chase offers new technologies which provide genetic testing beyond BRCA1 AND BRCA2

    by  • February 19, 2015 • Breast Cancer Treatment, Cancer Screening, Genetic Counseling, Risk Assessment, Women's Cancer Center

    When the Risk Assessment Program at Fox Chase Cancer Center decided it was time to begin offering the latest multigene genetic testing to our patients, we were confident that our team would be at the forefront of this rapidly changing field. Fox Chase began routinely offering these new tests to our patients in September,...

    Read more →

    Meet Michelle Savage, Fox Chase’s New Genetic Counselor

    by  • February 10, 2015 • Cancer Screening, Genetic Counseling, Risk Assessment

    Michelle Savage was born and raised in Bucks County, PA and grew up familiar with Fox Chase Cancer Center. She completed her undergraduate studies at Boston University, earning her BA in biology, with a concentration in cell biology, molecular biology and genetics. She studied genetic counseling at Arcadia University in Glenside, PA and completed...

    Read more →

    Minimizing Prostate Cancer Overdiagnosis without Missing the Target: Harnessing Fusion Technology to Overcome Limitations of PSA

    by  • November 11, 2014 • Active Surveillance, Cancer Screening, Prostate Cancer

    by David Y.T. Chen, MD, FACS, and Alexander Kutikov, MD, FACS In 2012, the United States Preventative Services Task Force (USPSTF) made the highly publicized and controversial recommendation advising against routine screening for prostate cancer with the prostate specific antigen (PSA) blood test. Even though prostate cancer is the most common cancer in US...

    Read more →